FI911701A - Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi Download PDF

Info

Publication number
FI911701A
FI911701A FI911701A FI911701A FI911701A FI 911701 A FI911701 A FI 911701A FI 911701 A FI911701 A FI 911701A FI 911701 A FI911701 A FI 911701A FI 911701 A FI911701 A FI 911701A
Authority
FI
Finland
Prior art keywords
carboxycarbapenems
substituted
preparation
therapeutically useful
therapeutically
Prior art date
Application number
FI911701A
Other languages
English (en)
Swedish (sv)
Other versions
FI95256B (fi
FI95256C (fi
FI911701A0 (fi
Inventor
Jr Carl B Ziegler
William V Curran
Gregg Feigelson
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI911701A0 publication Critical patent/FI911701A0/fi
Publication of FI911701A publication Critical patent/FI911701A/fi
Priority to FI943055A priority Critical patent/FI100327B/fi
Priority to FI943056A priority patent/FI100328B/fi
Publication of FI95256B publication Critical patent/FI95256B/fi
Application granted granted Critical
Publication of FI95256C publication Critical patent/FI95256C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI911701A 1990-04-10 1991-04-09 Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi FI95256C (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI943055A FI100327B (fi) 1990-04-10 1994-06-23 Uusia 4-propargyyli-2-okso-1-atsetidiinietikkahappojohdannaisia
FI943056A FI100328B (fi) 1990-04-10 1994-06-23 Uusia 4-allyyli-2-okso-1-atsetidiinietikkahappojohdannaisia

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/507,271 US5068232A (en) 1990-04-10 1990-04-10 Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them
US50727190 1990-04-10

Publications (4)

Publication Number Publication Date
FI911701A0 FI911701A0 (fi) 1991-04-09
FI911701A true FI911701A (fi) 1991-10-11
FI95256B FI95256B (fi) 1995-09-29
FI95256C FI95256C (fi) 1996-01-10

Family

ID=24017956

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911701A FI95256C (fi) 1990-04-10 1991-04-09 Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi

Country Status (20)

Country Link
US (3) US5068232A (fi)
EP (1) EP0478874A3 (fi)
JP (1) JPH04234885A (fi)
KR (1) KR0183020B1 (fi)
CN (3) CN1034332C (fi)
AU (1) AU634876B2 (fi)
CA (1) CA2039968A1 (fi)
CZ (1) CZ280808B6 (fi)
FI (1) FI95256C (fi)
HU (1) HU215606B (fi)
IE (1) IE910676A1 (fi)
IL (1) IL97275A (fi)
NO (1) NO178624C (fi)
NZ (1) NZ237610A (fi)
PH (1) PH27462A (fi)
PL (3) PL166336B1 (fi)
PT (1) PT97301B (fi)
SK (1) SK278900B6 (fi)
TW (1) TW229209B (fi)
ZA (1) ZA912629B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104838D0 (en) * 1991-03-07 1991-04-17 Glaxo Spa Heterocyclic compounds
US5189158A (en) * 1991-03-20 1993-02-23 American Cyanamid Company 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0939632B1 (en) * 1996-02-23 2005-10-05 Eli Lilly And Company NON-PEPTIDYL VASOPRESSIN V1a ANTAGONISTS
AU2002230290B2 (en) * 2001-02-16 2008-04-10 Pepscan Systems B.V. Arrays for determining binding of biomolecules
EP1765326A4 (en) * 2004-06-10 2009-05-13 Fob Synthesis Inc CARBAPENEM BACTERICIDES WITH GRAM-NEGATIVE ACTIVITY AND CORRESPONDING METHODS OF PREPARATION
KR20070061895A (ko) * 2004-10-08 2007-06-14 다이닛본 스미토모 세이야꾸 가부시끼가이샤 신규의 항균 약제
CN105906537B (zh) * 2016-04-27 2017-12-15 湖南科技学院 （z）式磺酰基烯酸酯化合物的一锅合成方法
CN105884663B (zh) * 2016-04-27 2017-12-15 湖南科技学院 一种(z)‑磺酰基烯酸酯的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122379A (en) * 1980-03-03 1981-09-25 Sankyo Co Ltd 1-carba-2-penem-3-carboxylic acid derivative
US4350631A (en) * 1980-12-18 1982-09-21 Merck & Co., Inc. 6- and 4-Substituted-1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylates
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
JPS58103388A (ja) * 1981-12-11 1983-06-20 Sankyo Co Ltd カルバペネム誘導体
JPH0649710B2 (ja) * 1984-08-06 1994-06-29 藤沢薬品工業株式会社 アゼチジノン誘導体およびその製造法
EP0184844A1 (en) * 1984-12-13 1986-06-18 Merck & Co. Inc. 1-Methylcarbapenems having a 2-position substituent joined through an alkylenethio bridge
US4882429A (en) * 1986-03-03 1989-11-21 Schering Corporation Stereospecific preparation of (3S,4R,5R)-3-(1-hydroxyethyl)-4-benzoyloxy-azeridinones from L-(-)-theonine
IT1197873B (it) * 1986-10-15 1988-12-21 Erba Farmitalia Procedimento per la preparazione di azetidinoni
US5021565A (en) * 1986-10-16 1991-06-04 Merck & Co., Inc. Novel 2-substituted alkyl carbapenem antibacterials
DE3779856T2 (de) * 1986-10-16 1993-03-25 Merck & Co Inc Antibakterielle, 2-substituierte alkyl-carbapeneme.
JPS63218659A (ja) * 1987-03-06 1988-09-12 Yasumitsu Tamura β−ラクタム化合物およびその製造法
JPH0193586A (ja) * 1987-10-05 1989-04-12 Yasumitsu Tamura カルバベネム化合物およびその製造法
US4960879A (en) * 1988-03-23 1990-10-02 Shionogi & Co., Ltd. Process for carbapenem intermediates
JPH0642853Y2 (ja) * 1988-10-28 1994-11-09 新王子製紙株式会社 プリンター
JPH03120280A (ja) * 1989-10-03 1991-05-22 Shionogi & Co Ltd ハロメチルカルバペネム化合物の製法

Also Published As

Publication number Publication date
PL165937B1 (pl) 1995-03-31
IL97275A0 (en) 1992-05-25
PT97301A (pt) 1992-01-31
PL165952B1 (pl) 1995-03-31
FI95256B (fi) 1995-09-29
EP0478874A3 (en) 1993-03-24
JPH04234885A (ja) 1992-08-24
HUT57770A (en) 1991-12-30
CN1037177C (zh) 1998-01-28
FI95256C (fi) 1996-01-10
PL289814A1 (en) 1992-08-10
NO911368D0 (no) 1991-04-09
NZ237610A (en) 1995-02-24
HU215606B (hu) 1999-01-28
IL97275A (en) 1996-01-31
CS92991A3 (en) 1992-04-15
PT97301B (pt) 1998-08-31
NO178624B (no) 1996-01-22
AU634876B2 (en) 1993-03-04
CN1034332C (zh) 1997-03-26
CN1034329C (zh) 1997-03-26
CN1108648A (zh) 1995-09-20
CA2039968A1 (en) 1991-10-11
AU7424891A (en) 1991-10-17
US5068232A (en) 1991-11-26
US5480987A (en) 1996-01-02
KR910018384A (ko) 1991-11-30
PL294071A1 (fi) 1993-02-08
NO178624C (no) 1996-05-02
PL166336B1 (pl) 1995-05-31
CZ280808B6 (cs) 1996-04-17
ZA912629B (en) 1992-01-29
HU911141D0 (en) 1991-10-28
NO911368L (no) 1991-10-11
EP0478874A2 (en) 1992-04-08
KR0183020B1 (ko) 1999-05-01
IE910676A1 (en) 1991-10-23
FI911701A0 (fi) 1991-04-09
SK278900B6 (sk) 1998-04-08
TW229209B (fi) 1994-09-01
PH27462A (en) 1993-07-09
CN1056878A (zh) 1991-12-11
US5369102A (en) 1994-11-29
CN1108649A (zh) 1995-09-20

Similar Documents

Publication Publication Date Title
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI883064A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
FI90769C (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
FI94752C (fi) Menetelmä terapeuttisesti käyttökelpoisten propenonioksiimieettereiden valmistamiseksi
FI930723A (fi) Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi
FI942907A (fi) Menetelmä lipaasin valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI892144A (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
NO178577C (no) Fremgangsmåte til fremstilling av cefalosporin
FI90658C (fi) Menetelmä terapeuttisesti käyttökelpoisen (E)-2-(p-fluorifenetyyli)-3-fluoriallyyliamiinin valmistamiseksi
FI102841B1 (fi) Menetelmä mannitolin valmistamiseksi
FI914874A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten C-3-ditioasetaalisubstituoitujen karbapeneemiyhdisteiden valmistamiseksi
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol

Legal Events

Date Code Title Description
BB Publication of examined application